DNA Methylation Biomarkers for Early Detection of Lung Cancer
Author Information
Author(s): Paul P Anglim, Todd A Alonzo, Ite A Laird-Offringa
Primary Institution: University of Southern California
Hypothesis
Can DNA methylation serve as a reliable biomarker for the early detection of non-small cell lung cancer (NSCLC)?
Conclusion
DNA methylation-based biomarkers show promise for the early detection of non-small cell lung cancer, potentially improving survival rates.
Supporting Evidence
- Lung cancer is the leading cause of cancer death, and early detection is crucial for improving survival rates.
- DNA methylation alterations are common in various cancers, making them a promising target for biomarker development.
- Studies indicate that DNA methylation can be detected in non-invasive samples like blood and sputum.
Takeaway
Scientists are studying changes in DNA to find signs of lung cancer early, which could help save lives.
Methodology
The review summarizes various studies on DNA methylation markers in NSCLC, focusing on their detection in different media.
Potential Biases
Potential biases may arise from differences in study populations and methodologies used to assess methylation.
Limitations
Many studies have low sensitivity and specificity, and the effectiveness of markers in diverse populations is still under investigation.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website